Seeking Alpha

Allergan (AGN +0.6%) moves up a bit today after JMP Securities ups the shares to Buy on the back...

Allergan (AGN +0.6%) moves up a bit today after JMP Securities ups the shares to Buy on the back of its Q4 results, and Stifel Nicolaus reiterated its Buy rating and raised its price target from $110 to $118. Stifel notes that 2013 guidance was actually robust, and strength can be seen in all its business lines, namely Botox with iOAB launch. Read more on AGN's earnings call here: Earnings Call Transcript.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs